NYSE American - Delayed Quote USD
Lineage Cell Therapeutics, Inc. (LCTX)
0.8105
+0.1080
+(15.37%)
At close: June 13 at 4:00:00 PM EDT
0.8052
-0.01
(-0.65%)
After hours: June 13 at 7:55:43 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.03 | -0.03 | -0.1 | -0.06 |
| Low Estimate | -0.04 | -0.03 | -0.12 | -0.12 |
| High Estimate | -0.02 | -0.01 | -0.08 | 0.02 |
| Year Ago EPS | -0.03 | -0.02 | -0.09 | -0.1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 1.47M | 1.89M | 6.7M | 23.11M |
| Low Estimate | 1.27M | 1.27M | 5.31M | -- |
| High Estimate | 1.92M | 3.8M | 9.6M | 37.51M |
| Year Ago Sales | 1.41M | 3.78M | 9.5M | 6.7M |
| Sales Growth (year/est) | 4.59% | -50.02% | -29.48% | 244.92% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.03 | -0.03 | -0.03 |
| EPS Actual | -0.03 | -0.02 | -0.01 | -0.02 |
| Difference | 0.01 | 0.01 | 0.02 | 0.01 |
| Surprise % | 25.00% | 39.99% | 66.67% | 28.57% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.03 | -0.1 | -0.06 |
| 7 Days Ago | -0.03 | -0.03 | -0.11 | -0.07 |
| 30 Days Ago | -0.03 | -0.03 | -0.12 | -0.09 |
| 60 Days Ago | -0.03 | -0.03 | -0.12 | -0.09 |
| 90 Days Ago | -0.04 | -0.04 | -0.1 | -0.11 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 4 | 2 |
| Up Last 30 Days | -- | 1 | 4 | 2 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LCTX | 0.00% | -33.35% | -16.67% | 44.45% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 3/14/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/11/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/31/2025 |
Related Tickers
GERN Geron Corporation
1.5100
-3.21%
MDWD MediWound Ltd.
20.42
+0.34%
ABP Abpro Corporation
0.2150
-11.85%
UBX Unity Biotechnology, Inc.
0.7980
-6.76%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4121
+14.79%
PALI Palisade Bio, Inc.
0.6401
-7.23%
ELEV Elevation Oncology, Inc.
0.3817
+0.39%
TNFA TNF Pharmaceuticals, Inc.
0.1370
-10.57%
CNTX Context Therapeutics Inc.
0.6294
-3.56%
RENB Renovaro Inc.
0.3653
-3.77%